Flu vaccine provided substantial protection during 2022-23 season
On Feb. 22, 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu vaccines…
On Feb. 22, 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu vaccines…
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
On Feb. 17, 2023, Moderna announced that Health Canada had authorized the use of its Omicron-targeting bivalent COVID-19…
On Feb. 16, 2023, National Institutes of Health (NIH) scientists announced they had developed and released an innovative…
On Feb. 15, 2023, Moderna announced it will continue to offer its COVID-19 vaccines for free, even after…
On Feb. 15, 2023, Researchers from Southwest University in China have constructed the entire chromosomal-scale genome assembly and…
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
On Feb. 23, 2023, Novavax announced a modification to its existing agreement with the U.S. Department of Health…
On Feb. 10, 2023, the U.S. Food and Drug Administration issued an emergency use authorization for the first…
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
On Feb. 7, 2023, an NIH funded study by University of North Carolina reported that Bivalent booster vaccines…
On Feb. 7, 2023, the U.S. Department of Agricultureメs Research Service announced that it was implementing a $300…
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
On Feb. 1, 2023, researchers funded by the National Institutes of Health announded they had developed a new…
On Jan. 26, 2023, the U.S. Food and Drug Administration revised the Emergency Use Authorization for Evusheld (tixagevimab…
On Jan. 26, 2023, Centers for Disease Control and Prevention (CDC) reported that U.S. household spread of flu…
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
On Jan. 18, 2023, Novavax announced that partner SK bioscience had received expanded manufacturing and marketing approval from…
On Jan. 18, 2023, researchers at the U.S. Department of Agriculture’s Agricultural Research Service announced they had bred…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 17, 2023, the Montana Fish and Wildlife Commission reported that juvenile grizzly bears tested positive for…
On Jan. 13, 2023, a team of researchers including faculty at the Translational Genomics Research Institute (TGen), part…
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 10, 2023, the National Institutes of Health reported that antiviral treatments can help reduce the risk…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 6, 2023, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway…